SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001437749-23-032344
Filing Date
2023-11-16
Accepted
2023-11-16 16:18:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D inbp20231116_sc13d.htm SC 13D 35275
  Complete submission text file 0001437749-23-032344.txt   37271
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filed by) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Subject) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-52311 | Film No.: 231414832
SIC: 2834 Pharmaceutical Preparations